Paris, France

Marc Piel



Average Co-Inventor Count = 1.6

ph-index = 2

Forward Citations = 119(Granted Patents)


Company Filing History:


Years Active: 2002-2005

Loading Chart...
Loading Chart...
2 patents (USPTO):Explore Patents

Title: The Innovative Contributions of Marc Piel

Introduction

Marc Piel is a notable inventor based in Paris, France, recognized for his contributions to the field of medical technology. With a total of two patents to his name, Piel has made significant strides in developing innovative solutions for healthcare applications.

Latest Patents

One of Marc Piel's latest patents is the Needleless Safety Syringe of Compact Architecture. This invention pertains to pre-filled disposable needleless syringes that operate with a gas generator. These syringes are designed for intradermal, subcutaneous, and intramuscular injections of liquid active principles for therapeutic purposes in both human and veterinary medicine. The inventive needleless syringe is characterized by a compact architecture, where the gas generator is released by a cap covering the body of the syringe. This cap is designed to slide along the body, providing great stability during the injection process.

Another significant patent is the Electronic Apparatus Shell, which showcases Piel's versatility in the field of invention.

Career Highlights

Throughout his career, Marc Piel has worked with various companies, including Crossject and Sport-elec S.A. His experience in these organizations has contributed to his expertise in developing innovative medical devices.

Collaborations

Marc Piel has collaborated with notable individuals in his field, including Patrick Alexandre and Bernard Brouquieres. These collaborations have likely enriched his work and led to further advancements in his inventions.

Conclusion

Marc Piel's contributions to the field of medical technology through his innovative patents demonstrate his commitment to improving healthcare solutions. His work continues to influence the industry and pave the way for future advancements.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…